Abstract:The clinical utility of molecular genetic testing relies on our accurate and comprehensive knowledge about the relationships between genes/variants and diseases/symptoms. Correctly interpreting the clinical significance of detected variants continues to be a constant challenge for molecular diagnostic practice. This challenge has become substantially magnified as testing based on next generation sequencing (NGS)3 becomes rapidly integrated in routine clinical practice.Whole exome sequencing for clinical diagnostics is a new practice. There are many challenges that lie ahead. One key issue out of many remains our ability to correctly interpret the clinical significance of gene variants, which lags far behind our ability to discover them. Consequently, many variants are currently categorized as variants of “unknown significance” in a clinical report. This certainly poses a challenge to physicians who receive the report, but we would argue that an even more pressing issue is the possibility of a false diagnosis: a non–disease-causing variant being interpreted as a pathogenic variant owing to our incorrect knowledge about gene/variant and disease/symptom associations. This possibility may be small for tests based on single genes or gene panels but markedly higher for tests based on whole exome sequencing/whole genome sequencing. Assigning a non–disease-causing variant as causative to a patient will deny the patient the future opportunity for identifying the real disease causation, and as a result the patient may never receive a truly correct disease diagnosis. Any such false diagnosis has the potential to have a huge impact on the care of the individual patient, on the diagnosis and management of family members who test negative or positive for the false-positive variant, and potentially on future family planning.DNA sequence variants can largely be grouped into 2 categories: truncating variants and nontruncating variants. Truncating variants consist of nonsense variants, out-of-frame indels, most splicing variants, and partial gene …

DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

DNA mismatch and damage patterns revealed by single-molecule sequencing

Advances in high throughput sequencing methods for DNA damage and repair

When a "Disease-Causing Mutation" is Not a Pathogenic Variant.

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Detection of ultra-rare mutations by next-generation sequencing

Accurate sequencing of DNA motifs able to form alternative structures

Abstract 5400: Accurate identification of single nucleotide variants in whole genome amplified single cells

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

Methods and applications of genome-wide profiling of DNA damage and rare mutations

Hidden Biases in Germline Structural Variant Detection.

Characterization of 26 Deletion CNVs Reveals the Frequent Occurrence of Micro-Mutations Within the Breakpoint-Flanking Regions and Frequent Repair of Double-Strand Breaks by Templated Insertions Derived from Remote Genomic Regions

Analysis of error profiles in deep next-generation sequencing data

Exploring DNA Damage and Repair Mechanisms: A Review with Computational Insights

Sequencing artifacts derived from a library preparation method using enzymatic fragmentation

Advances in Genotyping Detection of Fragmented Nucleic Acids

Strand-resolved mutagenicity of DNA damage and repair

Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification

Detecting and Quantitating Low Fraction DNA Variants with Low-Depth Sequencing

Mapping DNA polymerase errors by single-molecule sequencing